DEF: Phreesia, Inc. Announces 2025 Annual Meeting of Stockholders

Phreesia, Inc. will hold its 2025 Annual Meeting of Stockholders virtually on June 25, 2025, to elect directors, ratify the appointment of KPMG LLP, and approve executive compensation.

Summary

• Phreesia, Inc. is holding its 2025 Annual Meeting of Stockholders on June 25, 2025, virtually.
• Stockholders will vote on the election of two Class III directors, the ratification of KPMG LLP as the independent registered public accounting firm, and a non-binding advisory vote on executive compensation.
• The Board recommends voting FOR the election of the director nominees, FOR the ratification of KPMG LLP, and FOR the approval of executive compensation.
• The record date for determining stockholders eligible to vote is May 1, 2025.
• The proxy statement and annual report are available online at www.proxyvote.com.
• In fiscal year 2025, Phreesia's revenue was $419.8 million, up 18% year-over-year, and Adjusted EBITDA was $36.8 million.

Sentiment

Score: 7

Explanation: The document is generally positive, highlighting revenue growth and improved Adjusted EBITDA, but also acknowledges a net loss. The focus on corporate governance and executive compensation is standard for this type of document.

Positives

• The Board is committed to effective corporate governance and long-term stockholder interests.
• The Board is highly independent, with 7 of 8 directors meeting independence standards.
• The company has a diverse mix of experience, skills, and backgrounds on the Board.
• Phreesia's revenue increased to $419.8 million in fiscal year 2025, up 18% year-over-year.
• Adjusted EBITDA improved to $36.8 million in fiscal year 2025.

Negatives

• The company reported a net loss of $58.5 million in fiscal year 2025, although this is an improvement from the $136.9 million loss in the previous year.

Risks

• The advisory vote on executive compensation is non-binding, meaning the Board is not obligated to act in accordance with the outcome.
• The company's future performance is subject to various risks, including market conditions and competition.

Future Outlook

The document does not contain specific forward-looking statements beyond the standard business of the annual meeting.

Management Comments

• Chaim Indig, Chief Executive Officer, expressed gratitude for stockholders' ongoing support and continued interest in Phreesia.

Industry Context

The document provides information relevant to the healthcare technology and SaaS industries, particularly concerning executive compensation and corporate governance practices.

Comparison to Industry Standards

• The compensation committee reviews the compensation levels and practices of a group of comparable healthcare IT and SaaS companies.
• The companies in this compensation peer group were selected based on their similarity to us in characteristics such as market capitalization, size, shareholder return and industry focus.
• The primary criteria for our peers were that they are in the software industry and their market capitalization was similar to ours.
• Our market capitalization was near the median of this group at the time our peers were selected.

Related Party Transactions

• During the fiscal year ended January 31, 2025, Phreesia entered into statements of work with an advertising company for advertisements placed by Jazz Pharmaceuticals plc, pursuant to which Phreesia recognized revenue of approximately $1.3 million.
• Mark Smith, M.D., one of Phreesia's independent directors, also serves on the board of directors of Jazz Pharmaceuticals plc.
• The spouse of David Linetsky, Phreesia's SVP, Network Solutions, is a non-executive officer employee of Phreesia.

Stakeholder Impact

• The election of directors and approval of executive compensation directly impact shareholders.
• The company's performance and governance practices affect employees, customers, and other stakeholders.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will announce preliminary voting results at the Annual Meeting and disclose final results in a Current Report on Form 8-K.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Stockholders, Directors, Executive Compensation, KPMG, Corporate Governance, Phreesia